Notes / Company

Oxygenta Pharmaceutical Ltd.

OXYGENTAPH BSE 524636 ISIN INE102E01018 Pharmaceuticals

Fundamentals

Market cap: ₹187 cr
ROE: 38.69%
Debt / equity: -2.49
52-week range: 43.00 — 129.60

Research on Tijori Finance

Company snapshot

Oxygenta Pharmaceutical Ltd.

Pharmaceuticals

₹193 cr

Latest quarter · Jun 2026

Sales₹37 cr

Net profit−₹2 cr

Op. margin+1.5%

EPS−₹0.57

Strength & growth

Debt / equity-2.49×

Current ratio0.36×

Sales CAGR+28.4%

The timeline — 1 note on Oxygenta Pharmaceutical Ltd.

July 2026

27 Jul 26 · 6:08 PM IST Brief

Brief · Earnings · Micro cap

Oxygenta Pharma Q1 revenue surges 144%, loss narrows 66%

Revenue hits **₹37 cr** from **₹15 cr**; net loss shrinks to **₹2.1 cr**. AGM set for August 21.

Verify on exchange BSE filings for OXYGENTAPH NSE filings for OXYGENTAPH Tijori Finance company page